论文部分内容阅读
目的对思密达联合思连康治疗小儿秋季腹泻的临床效果进行观察与分析。方法选择2015年9月至2016年9月我院儿科收治的180例秋季腹泻患儿作为研究对象,随机分为对照组和观察组,两组患儿均给予常规治疗,对照组在常规治疗的基础上给予利巴韦林静滴,观察组在对照组的基础上给予思密达联合思连康治疗,比较两组患儿的临床治疗效果。结果治疗3d以后,观察组总有效率为95.56%,对照组总有效率为75.56%,观察组明显高于对照组,差异具有统计学意义。结论思密达与思连康两者联合应用治疗小儿秋季腹泻,可以明显改善患儿腹泻的临床症状、体征,显著提高治疗效果,值得临床推广应用。
Objective To observe and analyze the clinical effect of Smecta combined with Sili Kang in treating infantile autumn diarrhea. Methods A total of 180 children with autumnal diarrhea admitted to our hospital from September 2015 to September 2016 were selected as study subjects and randomly divided into control group and observation group. Both groups were given routine treatment. In control group, On the basis of ribavirin intravenous infusion, the observation group was given on the basis of the control group Smecta combined with Si Liankang treatment, the clinical efficacy of the two groups were compared. Results After 3 days of treatment, the total effective rate was 95.56% in the observation group and 75.56% in the control group, which was significantly higher in the observation group than in the control group. The difference was statistically significant. Conclusion Smecta combined with siliceous treatment of children with autumnal diarrhea can significantly improve the clinical symptoms and signs of children with diarrhea, significantly improve the therapeutic effect, it is worthy of clinical application.